| Income Statement |
| Total Revenue | 15.43M |
|
| Revenues (USD) | 15.43M |
| Cost of Revenue | 4.33M |
| Gross Profit | 11.10M |
| Operating Expenses | 14.75M |
| Research and Development Expense | 1.02M |
| Selling, General and Administrative Expense | 9.53M |
| Operating Income | -3.65M |
| Interest Expense | 4.15M |
| Net Income | -7.43M |
| Net Income Common Stock | -7.43M |
| Net Income Common Stock (USD) | -7.43M |
| Consolidated Income | -7.43M |
| Earnings per Basic Share | -0.09 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.09 |
| Earning Before Interest & Taxes (EBIT) | -3.28M |
| Earning Before Interest & Taxes (USD) | -3.28M |
| Weighted Average Shares | 86.04M |
| Weighted Average Shares Diluted | 86.04M |
| Balance Sheet |
| Cash and Equivalents | 4.77M |
| Cash and Equivalents (USD) | 4.77M |
| Trade and Non-Trade Receivables | 623.76K |
| Current Assets | 9.86M |
| Property, Plant & Equipment Net | 2.94M |
| Total Assets | 25.03M |
| Debt Current | 2.44M |
| Total Debt | 88.49M |
| Current Liabilities | 10.93M |
| Debt Non-Current | 86.05M |
| Total Liabilities | 97.33M |
| Accumulated Retained Earnings (Deficit) | -188.36M |
| Accumulated Other Comprehensive Income | -7.56M |
| Shareholders Equity | -72.29M |
| Shareholders Equity (USD) | -72.29M |
| Assets Non-Current | 15.18M |
| Total Debt (USD) | 88.49M |
| Deferred Revenue | 2.36M |
| Goodwill and Intangible Assets | 281.92K |
| Inventory | 1.92M |
| Liabilities Non-Current | 86.39M |
| Trade and Non-Trade Payables | 1.96M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 854.08M |
| Net Cash Flow from Financing | 2.75B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.04B |
| Capital Expenditure | -131.28M |
| Issuance (Repayment) of Debt Securities | 2.75B |
| Net Cash Flow from Investing | -131.28M |
| Net Cash Flow from Operations | -5.66B |
| Share Based Compensation | 2.22B |